De novo membranous glomerulopathy in a renal transplant patient treated with FK 506. The first reported case.
We describe a case of de novo membranous glomerulopathy in the renal allograft of a diabetic patient, treated with the newer immunosuppressive agent FK 506. Twenty-two months later this patient developed nephrotic range proteinuria.
Lal
S M
SM
Department of Internal Medicine, University of Missouri Health Sciences Center, Columbia, USA.
Luger
A M
AM
Hashefi
M
M
Ross
G
G
D001485:Basement Membrane / Q000473:pathology; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use; D003928:Diabetic Nephropathies / Q000601:surgery; D015433:Glomerulonephritis, Membranous / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000601:surgery; D007678:Kidney Glomerulus / Q000473:pathology; D016030:Kidney Transplantation; D008297:Male; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D016559:Tacrolimus / Q000009:adverse effects*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus